Literature DB >> 12792905

Review of renal oncocytoma with focus on clinical and pathobiological aspects.

N Kuroda1, M Toi, M Hiroi, T Shuin, H Enzan.   

Abstract

Renal oncocytomas account for about 3-7% of all renal tumors. Macroscopically, the cut surface of the tumor is generally mahogany brown or dark red in color. A central scar is occasionally observed. Histologically, tumor cells with finely granular cytoplasm proliferate in an edematous, myxomatous or hyalinized stroma with a nested, tubulocystic, solid or trabecular pattern. Ultrastructurally, tumor cells contain many mitochondria with lamellar cristae. Mitochondrial DNA alterations are consistently observed in renal oncocytomas. In chromosomal analysis, renal oncocytomas comprise a heterogenous group. Combined loss of chromosomes Y and 1, rearrangements affecting band 11q12-13, involvement of 12q12-13, loss of 14q, and the lack of combination of LOH at specific chromosomal sites have been reported. In differential diagnosis, the histological separation from chromophobe RCCs is of great importance. In such a setting, ultrastructural or chromosomal analysis is very useful. However, there are several findings suggesting a close relationship between chromophobe RCC and oncocytoma. First, both tumors share a phenotype of intercalated cells of the collecting duct system and mitochondrial DNA alterations. Second, some cases of coexistent oncocytoma and chromophobe RCC, designated as "renal oncocytosis", have recently been reported. Third, oncocytic variants of chromophobe RCCs that have similar ultrastructural features to those of oncocytomas have been reported. Fourth, the existence of chromophobe adenoma, which is the benign counterpart of chromophobe RCC and shows loss of chromosomes Y and 1, has recently been suggested. Finally, although almost all oncocytomas behave in a benign fashion, some cases of oncocytoma that caused metastasis or resulted in death have also been reported. Therefore, further studies are needed to resolve these problems and also to elucidate the genetic mechanisms responsible for the occurrence of oncocytomas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12792905     DOI: 10.14670/HH-18.935

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  27 in total

Review 1.  Mitochondria and cancer.

Authors:  Valdemar Máximo; Jorge Lima; Paula Soares; Manuel Sobrinho-Simões
Journal:  Virchows Arch       Date:  2009-04-03       Impact factor: 4.064

2.  LMP2, a novel immunohistochemical marker to distinguish renal oncocytoma from the eosinophilic variant of chromophobe renal cell carcinoma.

Authors:  Gang Zheng; Alcides Chaux; Rajni Sharma; George Netto; Patrizio Caturegli
Journal:  Exp Mol Pathol       Date:  2012-06-12       Impact factor: 3.362

3.  Immune signature of tumor infiltrating immune cells in renal cancer.

Authors:  Katharina Geissler; Paolo Fornara; Christine Lautenschläger; Hans-Jürgen Holzhausen; Barbara Seliger; Dagmar Riemann
Journal:  Oncoimmunology       Date:  2015-02-03       Impact factor: 8.110

Review 4.  Correlating Preoperative Imaging with Histologic Subtypes of Renal Cell Carcinoma and Common Mimickers.

Authors:  Jennifer Gordetsky; Jessica Zarzour
Journal:  Curr Urol Rep       Date:  2016-07       Impact factor: 3.092

5.  Simultaneous occurrence of non-Hodgkin lymphoma, renal cell carcinoma and oncocytoma: A case report.

Authors:  Ewa Zabrocka; Ewa Sierko; Stefan Jelski; Marek Z Wojtukiewicz
Journal:  Mol Clin Oncol       Date:  2016-07-27

6.  The UOK 257 cell line: a novel model for studies of the human Birt-Hogg-Dubé gene pathway.

Authors:  Youfeng Yang; Hesed M Padilla-Nash; Manish A Vira; Mones S Abu-Asab; Daniel Val; Robert Worrell; Maria Tsokos; Maria J Merino; Christian P Pavlovich; Thomas Ried; W Marston Linehan; Cathy D Vocke
Journal:  Cancer Genet Cytogenet       Date:  2008-01-15

Review 7.  Recent classification of renal epithelial tumors.

Authors:  Naoto Kuroda; Azusa Tanaka
Journal:  Med Mol Morphol       Date:  2013-03-26       Impact factor: 2.309

8.  Regulation of mitochondrial oxidative metabolism by tumor suppressor FLCN.

Authors:  Hisashi Hasumi; Masaya Baba; Yukiko Hasumi; Ying Huang; Hyoungbin Oh; Robert M Hughes; Mara E Klein; Shoichi Takikita; Kunio Nagashima; Laura S Schmidt; W Marston Linehan
Journal:  J Natl Cancer Inst       Date:  2012-11-12       Impact factor: 13.506

Review 9.  Functioning adrenocortical oncocytoma: the first documented case producing interleukin-6 and review of the literature.

Authors:  T Akatsu; K Kameyama; K Araki; T Ashizawa; G Wakabayashi; M Kitajima
Journal:  J Endocrinol Invest       Date:  2008-01       Impact factor: 4.256

10.  Chromophobe renal cell carcinoma, oncocytic variant: a proposal of a new variant giving a critical diagnostic pitfall in diagnosing renal oncocytic tumors.

Authors:  Naoto Kuroda; Azusa Tanaka; Tadanori Yamaguchi; Kotaro Kasahara; Keishi Naruse; Yosuke Yamada; Kanako Hatanaka; Nobuo Shinohara; Yoji Nagashima; Shuji Mikami; Mototsugu Oya; Takeru Hamashima; Michal Michal; Ondrej Hes
Journal:  Med Mol Morphol       Date:  2013-01-22       Impact factor: 2.309

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.